SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001358403-17-000150
Filing Date
2017-08-08
Accepted
2017-08-08 16:12:01
Documents
58
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q a2017q210q.htm 10-Q 765953
2 EXHIBIT 10.1 AGREEMENT exh101agreement.htm EX-10.1 67212
3 EXHIBIT 10.2 AMENDED AND RESTATED EMP AGMT exh102amendedagmt.htm EX-10.2 131858
4 EXHIBIT 31.1 exh3112017q2.htm EX-31.1 13330
5 EXHIBIT 31.2 exh3122017q2.htm EX-31.2 13498
6 EXHIBIT 32.1 exh3212017q2.htm EX-32.1 11626
  Complete submission text file 0001358403-17-000150.txt   4230579

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT blcm-20170630.xml EX-101.INS 773282
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT blcm-20170630.xsd EX-101.SCH 31530
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT blcm-20170630_cal.xml EX-101.CAL 57802
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT blcm-20170630_def.xml EX-101.DEF 128609
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT blcm-20170630_lab.xml EX-101.LAB 417529
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT blcm-20170630_pre.xml EX-101.PRE 237894
Mailing Address 2130 WEST HOLCOMBE BOULEVARD SUITE 800 HOUSTON TX 77030
Business Address 2130 WEST HOLCOMBE BOULEVARD SUITE 800 HOUSTON TX 77030 (832) 384-1100
BELLICUM PHARMACEUTICALS, INC (Filer) CIK: 0001358403 (see all company filings)

IRS No.: 201450200 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36783 | Film No.: 171014853
SIC: 2834 Pharmaceutical Preparations